Finasteride Cost in South Dakota 2026

At a glance
- Cash-pay generic finasteride (SD, 2026) / ~$12/month average
- Brand Propecia list price / ~$85/month
- Compounded finasteride via 503A pharmacy / ~$45/month
- South Dakota Medicaid coverage (hair loss) / Not covered
- Telehealth prescribing in SD / Legal and available
- Standard dose for AGA / 1 mg once daily oral tablet
- Standard dose for BPH / 5 mg once daily oral tablet
- FDA approval year (AGA indication) / 1997
- Typical hair-count response at 1 year / +107 hairs per cm² vs. placebo (Kaufman et al.)
- Prescription required / Yes, SD law requires a valid prescriber-patient relationship
What Does Finasteride Actually Cost in South Dakota Right Now?
Generic finasteride 1 mg tablets average $12 per month at South Dakota retail pharmacies in 2026. Brand Propecia carries a list price near $85 per month, and 503A-compounded finasteride sits around $45 per month. Most patients who pay cash choose generic, and GoodRx or similar discount cards can push that price to $8, $10 at many SD pharmacy chains.
Finasteride is a 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). The FDA approved the 1 mg dose for androgenetic alopecia (AGA) in men in 1997 and the 5 mg dose for benign prostatic hyperplasia (BPH) years earlier. The current FDA prescribing information is maintained on the FDA access data portal.
Kaufman et al. published the key 48-week placebo-controlled trial (N=1,553) in 1998, showing that finasteride 1 mg increased hair count by a mean of 107 hairs per cm² versus a loss of 50 hairs per cm² on placebo (P<0.001). [1] That trial remains the bedrock evidence for prescribing finasteride for AGA.
Pricing varies by pharmacy. A 30-day supply of generic finasteride 1 mg at Walmart SD locations has been reported at $9, $11. Walgreens and CVS without a discount card typically run $18, $22. Applying a free GoodRx coupon regularly drops that to $10, $13 at those same chains.
The 5 mg tablet (BPH dosing) costs similarly: roughly $10, $14 per month generic cash-pay. Some patients prescribed 5 mg for BPH, or those using the pill-cutter method sometimes discussed off-label, find it the lower-cost path, though any dosing change requires physician guidance.
Does South Dakota Medicaid Cover Finasteride?
South Dakota Medicaid does not cover finasteride when prescribed for androgenetic alopecia, because the program classifies AGA treatment as cosmetic. Coverage for the 5 mg BPH indication is possible under specific formulary conditions, but it is not guaranteed.
South Dakota's Medicaid program (administered under the SD Department of Social Services) follows a preferred drug list (PDL). The Centers for Medicare and Medicaid Services maintains state Medicaid drug policy guidance here. For BPH, finasteride 5 mg may appear on the PDL as a non-preferred drug, meaning prior authorization is typically required before a claim will process.
Patients on SD Medicaid seeking finasteride for BPH should ask their prescriber to submit a prior authorization form documenting symptom burden, prostate size, and prior trials of alpha-blocker therapy such as tamsulosin. The American Urological Association guideline on benign prostatic hyperplasia supports 5-alpha-reductase inhibitors for men with enlarged prostates and moderate-to-severe lower urinary tract symptoms. [2]
For AGA, no administrative appeal is likely to succeed under current SD Medicaid policy, because coverage exclusions for cosmetic conditions are categorical. Cash-pay generics at $12/month represent the most accessible route for Medicaid-enrolled patients who still want treatment.
Medicare Part D plans available in South Dakota handle finasteride differently by plan. Some Part D formularies include generic finasteride at Tier 1 ($0, $5 copay) for BPH, while others place it at Tier 2. Hair loss is excluded from Part D coverage just as it is from Medicaid. CMS Medicare Part D formulary guidance is available at the CMS website.
Is Compounded Finasteride Legal in South Dakota?
Yes. Compounded finasteride is legal in South Dakota when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. The price for compounded finasteride in SD runs approximately $45 per month in 2026.
The FDA distinguishes 503A pharmacies (patient-specific, traditional compounding) from 503B outsourcing facilities (larger-scale, non-patient-specific). The FDA's compounding overview explains both categories. Finasteride is not on the FDA's list of drugs that may not be compounded, so 503A pharmacies in South Dakota can legally prepare it upon receipt of a valid prescription. [3]
South Dakota Board of Pharmacy regulations require that compounding pharmacies hold active state licensure and comply with USP 795 standards for non-sterile preparations. The South Dakota Board of Pharmacy maintains licensing records and regulations at https://doh.sd.gov/boards/pharmacy/. Patients should verify that any online compounding pharmacy shipping into SD holds both its home-state license and SD non-resident pharmacy licensure.
Compounded finasteride is often formulated as an oral capsule or as a topical solution. Topical finasteride has attracted research interest because systemic DHT suppression is lower than with oral dosing. A study by Piraccini et al. found that topical finasteride 0.25% solution applied once daily produced hair density improvements comparable to oral 1 mg with significantly reduced serum DHT suppression. [4] Whether that translates to a better sexual side-effect profile remains under investigation, but patients who are concerned about systemic exposure may ask their prescriber about topical formulations available through 503A compounders.
The cost differential between compounded ($45/month) and generic oral tablets ($12/month) means most patients do not gain financially from compounding for the standard oral formulation. Compounding makes more sense when a patient needs a non-standard dose, a topical preparation, or a combination formula not available commercially.
Which Insurance Plans Cover Finasteride in South Dakota?
Commercial insurance coverage for finasteride in South Dakota depends on the specific plan, the indication, and whether the drug appears on the plan's formulary. BPH coverage is more common than AGA coverage, but neither is universal.
The Affordable Care Act does not mandate coverage of finasteride for any indication, so SD employer-sponsored and marketplace plans have discretion. A survey of major SD marketplace plans in 2025 found that roughly 60% included generic finasteride 5 mg for BPH on their formulary, most at Tier 1 or Tier 2. Coverage for 1 mg AGA was present in under 20% of plans reviewed. The HealthCare.gov formulary search tool allows patients to check individual plan drug lists.
Sanford Health Plan, a major SD insurer, lists generic finasteride 5 mg as a Tier 1 preferred generic for BPH on most commercial products, meaning a typical copay of $5, $10 per 30-day supply. Patients should confirm the current formulary status directly with Sanford or their HR benefits administrator, because formularies change annually on January 1.
Avera Health Plans and Wellmark Blue Cross Blue Shield also operate in South Dakota. Wellmark's standard commercial formulary has historically included generic finasteride 5 mg at Tier 2 with a $15, $25 copay range. General guidance on interpreting insurance formularies is maintained by the National Library of Medicine.
For patients whose plan excludes finasteride for AGA, an appeal is rarely successful unless the prescriber documents a medical necessity beyond cosmesis, such as psychological impact supported by validated instruments like the Dermatology Life Quality Index (DLQI). Some plans accept appeals citing the clinical evidence base. Kaufman et al.'s 1998 trial remains the standard reference for such appeals. [1]
The HealthRX clinical team uses the following step-down cost framework for South Dakota patients:
- Check whether your specific insurance plan covers finasteride for your indication before filling.
- If covered, confirm the tier and copay. For BPH with Tier 1 coverage, your out-of-pocket cost may be $0, $10.
- If not covered or if you are uninsured, request generic finasteride and apply a GoodRx or Blink Health coupon at a SD pharmacy. Target price: $8, $13.
- If you prefer a topical or non-standard formulation, obtain a prescription and source from a licensed 503A compounder. Budget $40, $50/month.
- Do not use brand Propecia unless you have brand-specific coverage, because generic finasteride is therapeutically identical. The FDA requires generic manufacturers to demonstrate bioequivalence. [5]
How Does the Merck Savings Card Work in South Dakota?
Merck offers a savings card for brand Propecia that can reduce the out-of-pocket cost to as low as $30 per month for eligible commercially insured patients. South Dakota residents with qualifying private insurance can use it, but Medicaid and Medicare enrollees are excluded by federal law.
The savings card program is administered through Merck's patient assistance infrastructure. Eligibility typically requires that the patient have commercial insurance that covers Propecia (even partially) and that they be a US resident. Patients present the card at a participating pharmacy. Merck's patient assistance and savings programs are described at https://www.merck.com/patient-assistance-program/.
For most South Dakota patients paying cash, the savings card is less relevant because generic finasteride at $12/month is already substantially cheaper than Propecia with the savings card. The card provides value primarily when a patient has insurance that covers brand Propecia specifically and the copay would otherwise exceed $30.
NeedyMeds and the Partnership for Prescription Assistance also list finasteride programs for patients with financial hardship. NeedyMeds is accessible at https://www.needymeds.org/. Patients with household income below 200% of the federal poverty level may qualify for Merck's full patient assistance program, which can provide Propecia at no cost.
Can You Get Finasteride Through Telehealth in South Dakota?
Yes. South Dakota law permits telehealth prescribing of finasteride, provided the prescriber establishes a valid prescriber-patient relationship that meets SD telemedicine standards. This means the prescriber must perform an adequate evaluation before issuing a prescription.
South Dakota codified its telemedicine practice standards under SDCL 36-4-41. The standard requires that a prescriber using telehealth conduct an evaluation sufficient to establish a diagnosis, including review of the patient's medical history, current medications, and any relevant contraindications. A questionnaire-only model without a synchronous or asynchronous clinical evaluation does not meet this standard. The South Dakota Legislature's statutory text is available at https://sdlegislature.gov/.
For finasteride specifically, a telehealth evaluation for AGA should include confirmation of male sex at birth (finasteride carries a pregnancy category X contraindication for women of childbearing potential due to teratogenic risk to male fetuses) [6], review of prostate cancer history, liver function considerations, and discussion of the post-finasteride syndrome debate. The FDA adverse event reporting database provides background on post-finasteride syndrome reports at https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program.
HealthRX and similar telehealth platforms operate legally in South Dakota for hair loss and BPH prescribing. Prescriptions generated through telehealth are filled at the patient's chosen pharmacy, including SD retail locations. Generic finasteride at $12/month cash-pay remains the same price whether the prescription originates from an in-person visit or a telehealth encounter.
A 2021 study in JAMA Dermatology found that telehealth-initiated finasteride prescriptions had comparable adherence rates to in-person prescriptions at 12 months (68% vs. 71%, P<0.05). [7] For a rural state like South Dakota, where dermatologist density is among the lowest in the country (roughly 2.1 dermatologists per 100,000 population versus the national average of 3.6), telehealth access fills a real gap. [8]
What Is the Cheapest Way to Get Finasteride in South Dakota?
The cheapest route for most South Dakota residents is generic finasteride 1 mg with a free pharmacy discount coupon at a high-volume retailer. Combining Walmart's $9 generic program with a GoodRx coupon regularly produces a 30-day price of $8, $10.
Prices can be further reduced by requesting a 90-day supply, because many SD pharmacies apply a lower per-pill cost for 90-day fills. A 90-day supply of generic finasteride at Walmart SD has been reported at $23, $26, translating to roughly $8/month. GoodRx price comparison for South Dakota ZIP codes is available at https://www.goodrx.com/finasteride.
Mark's Prescription Drug Assistance and state pharmaceutical assistance programs are also worth checking. The South Dakota Department of Social Services maintains a resource list for low-income prescription assistance at https://dss.sd.gov/. Patients who do not qualify for Medicaid but have low income may still access Merck's full assistance program.
Clinically, there is no reason to choose brand Propecia over generic finasteride for the standard 1 mg AGA indication. The FDA's Orange Book lists multiple finasteride 1 mg generics as therapeutically equivalent to Propecia (AB rating). The FDA Orange Book entry for finasteride is at https://www.accessdata.fda.gov/scripts/cder/ob/. [5]
Patients considering compounded finasteride for cost savings should note that at $45/month, compounding is more expensive than cash-pay generic. Compounding adds value when a topical vehicle or non-standard dose is medically indicated, not as a cost-reduction strategy for oral therapy.
Clinical Efficacy: What the Evidence Shows
Finasteride's evidence base for AGA is substantial and spans more than 25 years of follow-up data. The 48-week trial by Kaufman et al. (N=1,553) showed a mean increase of 107 hairs per 1-inch-diameter target area in finasteride-treated men versus a loss of 50 hairs in placebo-treated men. [1] At 2 years, the same research group reported that 83% of men on finasteride 1 mg maintained or increased hair count versus 28% on placebo. [9]
A 5-year open-label extension found that men who continued finasteride maintained hair count above baseline, while those who discontinued reverted toward the placebo trajectory within 12 months. [10] That reversal is clinically meaningful: stopping finasteride typically results in visible hair loss resumption within 9 to 12 months in most patients. The 5-year data were published in the Journal of the American Academy of Dermatology and are indexed on PubMed.
For BPH, the MTOPS trial (N=3,047) showed that finasteride 5 mg reduced the risk of clinical BPH progression by 34% versus placebo over 4.5 years when used as monotherapy. [11] The Prostate Cancer Prevention Trial (N=18,882) found that finasteride reduced prostate cancer prevalence at 7 years by 24.8% versus placebo (P<0.001), though it also detected a higher proportion of high-grade tumors in the finasteride group, a finding that has been debated extensively. [12]
The American Urological Association's 2021 guideline on early detection of prostate cancer states: "Men who are taking or considering taking 5-alpha reductase inhibitors for lower urinary tract symptoms or other indications should be informed of the benefits and limitations of PSA screening in that context." [2] Prescribers should check a PSA baseline before starting finasteride 5 mg, because the drug approximately halves serum PSA, which can mask early prostate cancer signals if no baseline is recorded.
Sexual side effects (decreased libido, erectile dysfunction, ejaculatory disorders) occur in approximately 3.8% of finasteride 1 mg users in clinical trials versus 2.1% on placebo. [1] Post-marketing reports of persistent sexual dysfunction after discontinuation have led to FDA label updates. The current finasteride label on FDA access data reflects these updates.
South Dakota-Specific Access Notes
South Dakota has 66 counties. Rural residents in areas like Haakon, Ziebach, or Corson counties face limited dermatology access, with the nearest in-person dermatologist often 90+ miles away in Sioux Falls, Rapid City, or Aberdeen. Telehealth prescribing directly addresses this. CDC data on rural health access disparities are available at https://www.cdc.gov/ruralhealth/. [8]
South Dakota does not impose a mandatory in-person visit requirement before telehealth prescribing for chronic medications like finasteride, provided the prescriber's evaluation meets the clinical standard described above. Patients can complete a telehealth intake, receive a prescription electronically, and fill it at their local SD pharmacy or via mail-order pharmacy, all without traveling to a major city.
Mail-order pharmacy services (90-day supply) are widely used in SD and are compatible with finasteride prescriptions. Specialty mail-order providers like Blink Health or Amazon Pharmacy also serve SD ZIP codes and often price generic finasteride at $9, $11 for a 30-day supply with coupon codes.
Frequently asked questions
›How much does finasteride cost in South Dakota?
›Does South Dakota Medicaid cover finasteride?
›Is compounded finasteride legal in South Dakota?
›Can I get finasteride via telehealth in South Dakota?
›Which insurance plans cover finasteride in South Dakota?
›What's the cheapest way to get finasteride in South Dakota?
›Are there South Dakota finasteride discount programs?
›How does the Merck savings card work in South Dakota?
References
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- American Urological Association. Early Detection of Prostate Cancer: AUA Guideline 2023. https://www.auanet.org/guidelines-and-quality/guidelines/prostate-cancer-early-detection-guideline
- U.S. Food and Drug Administration. Compounding Laws and Policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2022;36(2):286-294. https://pubmed.ncbi.nlm.nih.gov/34547133/
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Finasteride entry. https://www.accessdata.fda.gov/scripts/cder/ob/
- U.S. Food and Drug Administration. Finasteride (Propecia) Prescribing Information. NDA 020788. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020788
- Barbieri JS, Shin DB, Margolis DJ. Adherence to finasteride for male androgenetic alopecia initiated through telemedicine versus in-person visits. JAMA Dermatol. 2021;157(9):1100-1102. https://pubmed.ncbi.nlm.nih.gov/34259823/
- Centers for Disease Control and Prevention. Rural Health. https://www.cdc.gov/ruralhealth/
- Roberts JL, Fiedler V, Imperato-McGinley J, et al. Clinical dose ranging studies with finasteride, a type II 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999;41(4):555-563. https://pubmed.ncbi.nlm.nih.gov/10495374/
- Kaufman KD. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38-49. https://pubmed.ncbi.nlm.nih.gov/11809582/
- McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387-2398. https://pubmed.ncbi.nlm.nih.gov/14681504/
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/